Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
GCTK GlucoTrack	$0.13 +0.4%	$0.18	$0.13 ▼ $62.60	$3.82M	-0.14	2.33 million shs	939,661 shs
HSCS Heart Test Laboratories	$3.96 +2.3%	$3.27	$2.36 ▼ $7.57	$4.28M	2.61	121,914 shs	31,324 shs
NAOV NanoVibronix	$1.12 +2.8%	$4.37	$1.06 ▼ $16.25	$925K	2.03	841,517 shs	531,059 shs
NUWE Nuwellis	$0.93 +1.2%	$0.95	$0.75 ▼ $11.66	$4.06M	0.51	975,702 shs	28,370 shs

Investing Strategies To Help Grow Your Retirement Income

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
GCTK GlucoTrack	0.00%	-11.19%	-17.67%	-64.35%	-99.69%
HSCS Heart Test Laboratories	0.00%	+21.47%	+22.60%	+7.32%	-26.94%
NAOV NanoVibronix	0.00%	-8.94%	-81.02%	-73.47%	-86.06%
NUWE Nuwellis	0.00%	-1.35%	-0.65%	-28.62%	-89.15%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
GCTK GlucoTrack	0.5758 of 5 stars	0.0	3.0	1.1	1.7	0.6
HSCS Heart Test Laboratories	2.3948 of 5 stars	3.5	5.0	0.6	0.0	1.3
NAOV NanoVibronix	0.3166 of 5 stars	0.0	2.0	2.5	0.0	0.6
NUWE Nuwellis	2.4212 of 5 stars	3.5	5.0	0.6	0.0	1.3

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
GCTK GlucoTrack	0.00	N/A	N/A	N/A
HSCS Heart Test Laboratories	3.00	Buy	$13.00	228.28% Upside
NAOV NanoVibronix	0.00	N/A	N/A	N/A
NUWE Nuwellis	3.00	Buy	$17.00	1,731.90% Upside

Current Analyst Ratings Breakdown

Latest NAOV, NUWE, HSCS, and GCTK Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target	Details
5/13/2025	NUWE Nuwellis	Roth Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy
3/18/2025	HSCS Heart Test Laboratories	Ascendiant Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Buy ➝ Buy	$15.00 ➝ $14.00

(Data available from 5/25/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
GCTK GlucoTrack	N/A	N/A	N/A	N/A	$15.30 per share	N/A
HSCS Heart Test Laboratories	$14.70K	291.21	N/A	N/A	$11.16 per share	0.35
NAOV NanoVibronix	$2.56M	0.36	N/A	N/A	$1.95 per share	0.57
NUWE Nuwellis	$8.79M	0.46	N/A	N/A	$18.40 per share	0.05

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
GCTK GlucoTrack	-$7.10M	-$56.60	N/A	∞	N/A	N/A	-826.43%	-707.26%	N/A
HSCS Heart Test Laboratories	-$6.61M	-$7.48	N/A	N/A	N/A	N/A	-117.76%	-84.09%	8/4/2025 (Estimated)
NAOV NanoVibronix	-$3.71M	-$13.53	N/A	∞	N/A	-93.80%	-101.17%	-53.03%	8/12/2025 (Estimated)
NUWE Nuwellis	-$20.21M	-$18.24	N/A	N/A	N/A	-169.54%	-28,159.25%	-207.24%	8/12/2025 (Estimated)

Latest NAOV, NUWE, HSCS, and GCTK Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
5/20/2025	Q1 2025	NAOV NanoVibronix	N/A	-$3.98	N/A	-$3.98	N/A	$1.02 million
5/14/2025	Q1 2025	GCTK GlucoTrack	N/A	-$0.34	N/A	-$0.67	N/A	N/A
5/13/2025	Q1 2025	NUWE Nuwellis	-$0.45	-$0.69	-$0.24	-$0.69	$2.50 million	$1.90 million
3/13/2025	Q3 2025	HSCS Heart Test Laboratories	-$2.53	-$2.5722	-$0.0422	-$2.57	N/A	N/A

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
GCTK GlucoTrack	N/A	N/A	N/A	N/A	N/A
HSCS Heart Test Laboratories	N/A	N/A	N/A	N/A	N/A
NAOV NanoVibronix	N/A	N/A	N/A	N/A	N/A
NUWE Nuwellis	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
GCTK GlucoTrack	N/A	0.14	0.14
HSCS Heart Test Laboratories	0.01	1.72	1.52
NAOV NanoVibronix	N/A	1.74	0.84
NUWE Nuwellis	N/A	2.03	1.34

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
GCTK GlucoTrack	10.92%
HSCS Heart Test Laboratories	17.24%
NAOV NanoVibronix	16.39%
NUWE Nuwellis	3.13%

Insider Ownership

Company	Insider Ownership
GCTK GlucoTrack	46.50%
HSCS Heart Test Laboratories	1.80%
NAOV NanoVibronix	7.00%
NUWE Nuwellis	1.60%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
GCTK GlucoTrack	5	28.64 million	5.57 million	Not Optionable
HSCS Heart Test Laboratories	10	1.08 million	962,000	Not Optionable
NAOV NanoVibronix	20	826,000	3.49 million	Not Optionable
NUWE Nuwellis	70	4.37 million	4.26 million	Not Optionable

NAOV, NUWE, HSCS, and GCTK Headlines

Recent News About These Companies

Research Analysts Offer Predictions for Nuwellis Q2 Earnings

May 18, 2025 | americanbankingnews.com

Earnings call transcript: Nuwellis Q1 2025 shows growth in revenue, stock stable

May 14, 2025 | investing.com

Nuwellis Inc (NUWE) Q1 2025 Earnings Call Highlights: Strategic Growth Amidst Operational Challenges

May 14, 2025 | finance.yahoo.com

Nuwellis, Inc. (NASDAQ:NUWE) Q1 2025 Earnings Call Transcript

May 14, 2025 | msn.com

Q1 2025 Nuwellis Inc Earnings Call

May 14, 2025 | finance.yahoo.com

Nuwellis, Inc. Partners with KDI Precision Manufacturing to Streamline Operations and Enhance Aquadex Product Manufacturing

May 13, 2025 | nasdaq.com

Nuwellis, Inc. Reports First Quarter 2025 Financial Results and Business Highlights

May 13, 2025 | manilatimes.net

Nuwellis, Inc. (NUWE) Q1 2025 Earnings Call Transcript

May 13, 2025 | seekingalpha.com

Nuwellis, Inc. (NUWE) Reports Q1 Loss, Lags Revenue Estimates

May 13, 2025 | zacks.com

Nuwellis, Inc. Reports First Quarter 2025 Financial Results and Business Highlights

May 13, 2025 | globenewswire.com

Nuwellis, Inc.: Nuwellis Contracts with KDI Precision Manufacturing to Strengthen Production and Improve Operational Efficiency

May 13, 2025 | finanznachrichten.de

Nuwellis Q1 Earnings Preview

May 13, 2025 | msn.com

Nuwellis Contracts with KDI Precision Manufacturing to Strengthen Production and Improve Operational Efficiency

May 12, 2025 | globenewswire.com

Nuwellis Expands Aquadex® for Pediatric Fluid Management to Two New Hospital Systems

May 8, 2025 | globenewswire.com

Nuwellis Expands IP Portfolio with Patent That Reduces Clinical Burden, Preserves Precision

April 24, 2025 | globenewswire.com

Nuwellis, Inc. To Report First Quarter 2025 Financial Results on May 13, 2025

April 22, 2025 | globenewswire.com

Nuwellis, Inc. (NASDAQ:NUWE) Q4 2024 Earnings Call Transcript

March 12, 2025 | msn.com

Nuwellis price target lowered to $13 from $16 at Roth MKM

March 11, 2025 | markets.businessinsider.com

Nuwellis, Inc. (NUWE) Q4 2024 Earnings Call Transcript

March 11, 2025 | seekingalpha.com

Nuwellis, Inc. (NUWE) Reports Q4 Loss, Lags Revenue Estimates

March 11, 2025 | zacks.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

NAOV, NUWE, HSCS, and GCTK Company Descriptions

GlucoTrack NASDAQ:GCTK

$0.13 +0.00 (+0.38%)

Closing price 05/23/2025 04:00 PM Eastern

Extended Trading

$0.13 0.00 (-0.23%)

As of 05/23/2025 07:53 PM Eastern

GlucoTrack, Inc., a medical device company, focused on the design, development, and commercialization of novel technologies for people with diabetes in the United States. It develops GlucoTrack, a noninvasive glucose monitoring device that helps people with diabetes and pre-diabetics to obtain blood glucose level readings without the pain. The company was formerly known as Integrity Applications, Inc. and changed its name to GlucoTrack, Inc. in November 2021. GlucoTrack, Inc. was founded in 2001 and is based in Rutherford, New Jersey.

Heart Test Laboratories NASDAQ:HSCS

$3.96 +0.09 (+2.33%)

Closing price 05/23/2025 03:53 PM Eastern

Extended Trading

$3.92 -0.04 (-1.01%)

As of 05/23/2025 06:52 PM Eastern

Heart Test Laboratories, Inc., a medical technology company, provides cardiovascular diagnostic devices. The company offers MyoVista wavECG, a resting 12-lead electrocardiograph (ECG) to provide diagnostic information related to cardiac dysfunction, as well as conventional ECG information. It serves clinics, doctor's offices, urgent care centers, and hospitals. The company was incorporated in 2007 and is headquartered in Southlake, Texas.

NanoVibronix NASDAQ:NAOV

$1.12 +0.03 (+2.75%)

Closing price 05/23/2025 04:00 PM Eastern

Extended Trading

$1.12 -0.01 (-0.45%)

As of 05/23/2025 07:59 PM Eastern

NanoVibronix, Inc., through its subsidiary, NanoVibronix Ltd., focuses on the manufacture and sale of noninvasive biological response-activating devices that target biofilm prevention, wound healing, and pain therapy. Its product portfolio includes UroShield, an ultrasound-based product to prevent bacterial colonization and biofilm in urinary catheters, enhance antibiotic efficacy, and decrease pain and discomfort associated with urinary catheter use. The company also offers PainShield, a patch-based therapeutic ultrasound technology to treat pain, muscle spasm, and joint contractures; and WoundShield, a patch-based therapeutic ultrasound device intended to facilitate tissue regeneration and wound healing by using ultrasound to increase local capillary perfusion and tissue oxygenation. It sells its products directly to patients, as well as through distributor agreements in the United States, Israel, Europe, Australia, India, and internationally. The company was incorporated in 2003 and is headquartered in Elmsford, New York.

Nuwellis NASDAQ:NUWE

$0.93 +0.01 (+1.20%)

Closing price 05/23/2025 04:00 PM Eastern

Extended Trading

$0.96 +0.04 (+3.99%)

As of 05/23/2025 06:50 PM Eastern

Nuwellis, Inc., a medical device company, develops, manufactures, and commercializes medical devices used in ultrafiltration therapy. The company offers Aquadex FlexFlow and Aquadex SmartFlow systems, which are used to treat patients suffering from fluid overload due to heart failure. Its Aquadex FlexFlow system includes a console, disposable blood circuit set, and disposable catheter. The company sells its products to hospitals and clinics through its direct salesforce in the United States; and through independent specialty distributors in Austria, Belarus, Brazil, Colombia, the Czech Republic, Germany, Greece, Hong Kong, India, Israel, Italy, Panama, Romania, Singapore, Slovakia, Spain, Switzerland, Thailand, the United Arab Emirates, and the United Kingdom. The company was formerly known as CHF Solutions, Inc. and changed its name to Nuwellis, Inc. in April 2021. Nuwellis, Inc. was founded in 1999 and is headquartered in Eden Prairie, Minnesota.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time